Clinical Trials Directory

Trials / Sponsors / Zosano Pharma Corporation

Zosano Pharma Corporation

Industry · 9 registered clinical trials.

StatusTrialPhaseStarted
CompletedStudy of PK, Safety, and Tolerability of 2 Lots of M207 & Intranasal Zolmitriptan in Healthy Volunteers
Migraine
Phase 12021-06-24
CompletedDouble-Blind Comparison of the Efficacy and Safety of C213 to Placebo for the Acute Treatment of Cluster Heada
Cluster Headache
Phase 2 / Phase 32019-10-03
CompletedA Four-way Crossover Study of 3 Formulations of M207 With Intranasal Zolmitriptan in Healthy Volunteers
Migraine
Phase 12019-05-29
CompletedA Study of M207 With Intranasal Zolmitriptan in Healthy Volunteers
Migraine
Phase 12018-11-01
CompletedA Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
Migraine
Phase 32017-11-07
CompletedSafety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine
Acute Migraine
Phase 2 / Phase 32016-06-01
CompletedA Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forte
Postmenopausal Osteoporosis
Phase 12015-06-01
CompletedSafety and Efficacy of ZP-Glucagon to Injectable Glucagon for Hypoglycemia
Hypoglycemia
Phase 12015-01-01
CompletedDose Ranging Study - Macroflux Parathyroid Hormone (PTH) in Postmenopausal Women With Osteoporosis
Osteoporosis
Phase 22007-06-01